Morning Overview on MSN
A modified HIV drug reversed vision loss and paralysis in mice with MS
Mice that could no longer use their legs or see properly regained both functions after treatment with kamuvudine-9, a ...
Biodesign brings clinicians, engineers, and other experts together to address real clinical needs, while accounting for regulatory, financial and workflow barriers.
A combination of the cannabinoid cannabigerol (CBG) and certain terpenes significantly reduced DNA damage, oxidative stress ...
IEEE Spectrum on MSN
Tech to replace animal testing is almost ready. Scientists are not
Changing habits may be the hardest engineering challenge of all ...
(NYSE American:NNVC) (the "Company"), a clinical stage leader developing antiviral drugs that viruses cannot escape, herewith provides additional details on its Phase II Clinical Trial of NV-387 Oral ...
Every day, hundreds of thousands of people undergo general anesthesia, trusting they'll drift into unconsciousness and wake ...
PackGene Biotech announced today at the Cell & Gene Meeting on the Mesa the delivery of client AAV manufacturing projects through the Dyno Frontiers Network, supporting gene therapy programs that use ...
A paper has been published on the creation of a disease model for multiple sclerosis using organoids. I am introducing this ...
The human nose is the first checkpoint of the respiratory tract, a thin, moist lining where viruses such as influenza A make ...
Airway stem cell transplantation achieves functional restoration and long-term engraftment in preclinical models, promising new opportunities for patients without gene-targeted options.
A mouse study from WashU Medicine suggests a new approach to preventing brain cell death from certain neurological diseases.
A new approach allowed scientists to trace the changes in grass abundance and diversity in one site over a period of 25,000 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results